




Searching News Database: antibiotic
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 18 Jan 2024
Cepheid Receives Expanded FDA Clearance with CLIA Waiver for Xpert(R) Xpress MVP
Cepheid Receives Expanded FDA Clearance with CLIA Waiver for Xpert(R) Xpress MVP
HSMN NewsFeed - 23 Dec 2022
Hyphens Pharma Licenses Winlevi(R) for All 10 ASEAN countries from Cosmo Pharmaceuticals
Hyphens Pharma Licenses Winlevi(R) for All 10 ASEAN countries from Cosmo Pharmaceuticals
HSMN NewsFeed - 21 Dec 2022
Biomica Raises $20 Million in a Financing Round to Advance its Pipeline of Microbiome-based Therapeutics
Biomica Raises $20 Million in a Financing Round to Advance its Pipeline of Microbiome-based Therapeutics
HSMN NewsFeed - 29 Sep 2022
MolecuLight Point-of-Care Wound Imaging Devices Awarded Group Purchasing Agreement with AllSpire Health GPO
MolecuLight Point-of-Care Wound Imaging Devices Awarded Group Purchasing Agreement with AllSpire Health GPO
HSMN NewsFeed - 1 Aug 2022
Armata Pharmaceuticals Announces Clearance of IND for Prosthetic Joint Infections
Armata Pharmaceuticals Announces Clearance of IND for Prosthetic Joint Infections
HSMN NewsFeed - 14 Jun 2022
MolecuLight Awarded Point-of-Care Wound Imaging Devices Agreement with Premier, Inc.
MolecuLight Awarded Point-of-Care Wound Imaging Devices Agreement with Premier, Inc.
HSMN NewsFeed - 14 Apr 2022
NCCN Guidelines(R) Recommend VONJO(TM) (pacritinib) for the Treatment of Myeloproliferative Neoplasms
NCCN Guidelines(R) Recommend VONJO(TM) (pacritinib) for the Treatment of Myeloproliferative Neoplasms
HSMN NewsFeed - 30 Aug 2021
Visby Medical(TM) Receives FDA Clearance and CLIA Waiver at the Point of Care for PCR Sexual Health Test
Visby Medical(TM) Receives FDA Clearance and CLIA Waiver at the Point of Care for PCR Sexual Health Test
HSMN NewsFeed - 8 Jan 2021
Blacksmith Medicines Launches With Seed Funding and a Research Collaboration With Lilly
Blacksmith Medicines Launches With Seed Funding and a Research Collaboration With Lilly
HSMN NewsFeed - 12 Nov 2020
Valeo Pharma announces Amikacin approval in CANADA and U.S. launch of Ethacrynate Sodium
Valeo Pharma announces Amikacin approval in CANADA and U.S. launch of Ethacrynate Sodium
HSMN NewsFeed - 12 Nov 2020
Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of Directors
Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of Directors
HSMN NewsFeed - 26 Oct 2020
Armata Pharmaceuticals Appoints Mina Pastagia, MD, MS as Vice President of Clinical Development
Armata Pharmaceuticals Appoints Mina Pastagia, MD, MS as Vice President of Clinical Development
HSMN NewsFeed - 22 Sep 2020
NanoVibronix UroShield(R) Receives U.S. Food and Drug Administration Authorization for Entry into the U.S.
NanoVibronix UroShield(R) Receives U.S. Food and Drug Administration Authorization for Entry into the U.S.
HSMN NewsFeed - 18 Jun 2020
Almirall Announces FDA Approval Of Updated Label For Seysara(R) (Sarecycline) Tablets
Almirall Announces FDA Approval Of Updated Label For Seysara(R) (Sarecycline) Tablets
HSMN NewsFeed - 29 May 2020
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
HSMN NewsFeed - 15 May 2020
Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
HSMN NewsFeed - 4 May 2020
SutroVax Appoints Andrew Guggenhime as Chief Financial Officer and Chief Business Officer
SutroVax Appoints Andrew Guggenhime as Chief Financial Officer and Chief Business Officer
HSMN NewsFeed - 16 Mar 2020
ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
HSMN NewsFeed - 5 Mar 2020
Magnolia Medical Receives FDA 510(k) Clearance for Expanded Steripath Gen2 Product Family
Magnolia Medical Receives FDA 510(k) Clearance for Expanded Steripath Gen2 Product Family
HSMN NewsFeed - 28 Jan 2020
Beckman Coulter's Access PCT Procalcitonin Assay Receives U.S. FDA 510(k) Clearance
Beckman Coulter's Access PCT Procalcitonin Assay Receives U.S. FDA 510(k) Clearance
HSMN NewsFeed - 2 Jan 2020
Aridis Pharmaceuticals Appoints Michael A. Nazak as Chief Financial Officer
Aridis Pharmaceuticals Appoints Michael A. Nazak as Chief Financial Officer
HSMN NewsFeed - 24 Dec 2019
Correvio Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events
Correvio Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events
HSMN NewsFeed - 11 Dec 2019
Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value
Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value
HSMN NewsFeed - 18 Nov 2019
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
HSMN NewsFeed - 4 Nov 2019
Accelerate Diagnostics Appoints Roland Diggelmann to its Board of Directors
Accelerate Diagnostics Appoints Roland Diggelmann to its Board of Directors
HSMN NewsFeed - 25 Oct 2019
Microbion Corporation Announces Generic Name for Lead Antimicrobial Compound: Pravibismane
Microbion Corporation Announces Generic Name for Lead Antimicrobial Compound: Pravibismane
HSMN NewsFeed - 8 Oct 2019
Sekisui Diagnostics Announces FDA Clearance and CLIA Waiver of the Acucy(TM) Influenza A&B Test
Sekisui Diagnostics Announces FDA Clearance and CLIA Waiver of the Acucy(TM) Influenza A&B Test
HSMN NewsFeed - 16 Sep 2019
Soligenix Appoints Daniel P. Ring as Vice President of Business Development and Strategic Planning
Soligenix Appoints Daniel P. Ring as Vice President of Business Development and Strategic Planning
HSMN NewsFeed - 25 Jul 2019
U.S. FDA Accepts Correvio's Resubmitted New Drug Application For Brinavess (vernakalant)
U.S. FDA Accepts Correvio's Resubmitted New Drug Application For Brinavess (vernakalant)
HSMN NewsFeed - 19 Jul 2019
Aridis Pharmaceuticals Receives Orphan Drug Designation From the European Medicines Agency for AR-501
Aridis Pharmaceuticals Receives Orphan Drug Designation From the European Medicines Agency for AR-501
HSMN NewsFeed - 8 Jul 2019
Soligenix Announces Appointment of Diane L. Parks to its Board of Directors
Soligenix Announces Appointment of Diane L. Parks to its Board of Directors
HSMN NewsFeed - 21 Jun 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
HSMN NewsFeed - 10 Jun 2019
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
HSMN NewsFeed - 16 Apr 2019
Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors
Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors
HSMN NewsFeed - 9 Apr 2019
Bluejay Diagnostics, Inc. Announces CE Mark For Its Allereye(R) Tear Total IgE Test
Bluejay Diagnostics, Inc. Announces CE Mark For Its Allereye(R) Tear Total IgE Test
HSMN NewsFeed - 27 Mar 2019
Synspira Therapeutics Announces Appointment of Robert Gallotto as President and Chief Executive Officer
Synspira Therapeutics Announces Appointment of Robert Gallotto as President and Chief Executive Officer
HSMN NewsFeed - 2 Jan 2019
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
HSMN NewsFeed - 7 Nov 2018
HemoScreen(TM) Hematology Analyzer for Point of Care, Receives FDA 510(k) Clearance
HemoScreen(TM) Hematology Analyzer for Point of Care, Receives FDA 510(k) Clearance
HSMN NewsFeed - 17 Sep 2018
U.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne
U.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne
HSMN NewsFeed - 26 Jul 2018
Cepheid Receives FDA Clearance and CLIA Waiver for Xpert(R) Xpress Flu/RSV Test
Cepheid Receives FDA Clearance and CLIA Waiver for Xpert(R) Xpress Flu/RSV Test
HSMN NewsFeed - 24 Jul 2018
Soligenix Announces Appointment of Mark Pearson to its Board of Directors
Soligenix Announces Appointment of Mark Pearson to its Board of Directors
HSMN NewsFeed - 19 Jun 2018
GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests
GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests
HSMN NewsFeed - 11 Jun 2018
Roche introduces first self-testing device for Warfarin monitoring with built in Bluetooth(R) technology
Roche introduces first self-testing device for Warfarin monitoring with built in Bluetooth(R) technology
HSMN NewsFeed - 24 May 2018
BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance
BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance
HSMN NewsFeed - 17 May 2018
Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess(R) in China
Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess(R) in China
HSMN NewsFeed - 17 Apr 2018
Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess(R)
Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess(R)
HSMN NewsFeed - 16 Apr 2018
Roche receives FDA clearance for cobas(R) CT/NG for cobas(R) 6800/8800 Systems
Roche receives FDA clearance for cobas(R) CT/NG for cobas(R) 6800/8800 Systems
HSMN NewsFeed - 8 Mar 2018
Roche launches the new cobas m 511 analyzer, signaling a new era in hematology testing
Roche launches the new cobas m 511 analyzer, signaling a new era in hematology testing
HSMN NewsFeed - 8 Feb 2018
N8 Medical Submits IDE for Breakthrough CeraShield(TM) Endotracheal Tube Device
N8 Medical Submits IDE for Breakthrough CeraShield(TM) Endotracheal Tube Device
HSMN NewsFeed - 5 Feb 2018
FDA Clears Oricula Therapeutics Investigational New Drug Application for Clinical Trials
FDA Clears Oricula Therapeutics Investigational New Drug Application for Clinical Trials
HSMN NewsFeed - 15 Jan 2018
BD and Check-Points Receive CE Mark for Next-generation Resistant Bacteria Screening Test
BD and Check-Points Receive CE Mark for Next-generation Resistant Bacteria Screening Test
HSMN NewsFeed - 19 Dec 2017
Inflammatix Announces Appointment of Oliver Liesenfeld, M.D., as Chief Medical Officer
Inflammatix Announces Appointment of Oliver Liesenfeld, M.D., as Chief Medical Officer
HSMN NewsFeed - 12 Dec 2017
Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
HSMN NewsFeed - 2 Oct 2017
Alere Receives FDA Clearance for Alere(TM) i Influenza A & B 2 Rapid Molecular Test
Alere Receives FDA Clearance for Alere(TM) i Influenza A & B 2 Rapid Molecular Test
HSMN NewsFeed - 18 Sep 2017
Tetracore(R) Inc. Announces European Approval of the T-COR 8(TM) Portable Real-time PCR Thermocycler
Tetracore(R) Inc. Announces European Approval of the T-COR 8(TM) Portable Real-time PCR Thermocycler
HSMN NewsFeed - 18 Sep 2017
Kaleido Biosciences Announces Appointment of Mike Bonney as CEO and Completion of Additional Fundraising
Kaleido Biosciences Announces Appointment of Mike Bonney as CEO and Completion of Additional Fundraising
HSMN NewsFeed - 12 Sep 2017
T.R.U.E. Test(R) Ready-To-Use Patch Test Receives FDA Approval For Pediatric Use
T.R.U.E. Test(R) Ready-To-Use Patch Test Receives FDA Approval For Pediatric Use
HSMN NewsFeed - 12 Sep 2017
Synthetic Biologics Announces Closing of $12 Million Convertible Preferred Stock Financing
Synthetic Biologics Announces Closing of $12 Million Convertible Preferred Stock Financing
HSMN NewsFeed - 26 Jul 2017
Roche Launches the Avenio Millisect System for Precise and Efficient Dissection of Tissue Biopsies
Roche Launches the Avenio Millisect System for Precise and Efficient Dissection of Tissue Biopsies
HSMN NewsFeed - 1 Jun 2017
GenePOC Announces FDA Clearance for Revogene(TM) Instrument and its GBS LB Test
GenePOC Announces FDA Clearance for Revogene(TM) Instrument and its GBS LB Test
HSMN NewsFeed - 26 Apr 2017
FDA Approves XATMEP(TM), the First and Only Ready-To-Use Methotrexate Oral Solution
FDA Approves XATMEP(TM), the First and Only Ready-To-Use Methotrexate Oral Solution
HSMN NewsFeed - 25 Apr 2017
Magnolia Medical Appoints Robert E. Gerberich As Chief Commercial Officer
Magnolia Medical Appoints Robert E. Gerberich As Chief Commercial Officer
HSMN NewsFeed - 12 Apr 2017
Roche Launches Antibody Test to Aid in Diagnosis of Challenging Prostate Cancer Cases
Roche Launches Antibody Test to Aid in Diagnosis of Challenging Prostate Cancer Cases
HSMN NewsFeed - 14 Mar 2017
BONESUPPORT(TM) Extends U.S. Distribution Agreement for CERAMENT(TM)|BONE VOID FILLER
BONESUPPORT(TM) Extends U.S. Distribution Agreement for CERAMENT(TM)|BONE VOID FILLER
HSMN NewsFeed - 8 Mar 2017
Spero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing
Spero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing
HSMN NewsFeed - 22 Feb 2017
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
HSMN NewsFeed - 22 Feb 2017
BD Veritor(TM) System Meets FDA's New Performance Requirements for Rapid Influenza Antigen Detection Tests
BD Veritor(TM) System Meets FDA's New Performance Requirements for Rapid Influenza Antigen Detection Tests
HSMN NewsFeed - 30 Jan 2017
AmpliPhi Biosciences Appoints Dr. Igor P. Bilinsky as Senior Vice President and Chief Operating Officer
AmpliPhi Biosciences Appoints Dr. Igor P. Bilinsky as Senior Vice President and Chief Operating Officer
HSMN NewsFeed - 8 Dec 2016
Cardiome Announces Commercial Launch of Xydalba(TM) (dalbavancin) in the UK
Cardiome Announces Commercial Launch of Xydalba(TM) (dalbavancin) in the UK
HSMN NewsFeed - 7 Nov 2016
BONESUPPORT(TM) Announces Key Corporate Appointment To Drive Growth In North America
BONESUPPORT(TM) Announces Key Corporate Appointment To Drive Growth In North America
HSMN NewsFeed - 26 Sep 2016
MicuRx Closes $55 Million Series C Financing to Support Development of Next-Generation Antibiotic MRX-I
MicuRx Closes $55 Million Series C Financing to Support Development of Next-Generation Antibiotic MRX-I
HSMN NewsFeed - 9 Sep 2016
BioVie's Lead Compound BIV201 Receives FDA Orphan-Drug Designation for the Treatment of Ascites
BioVie's Lead Compound BIV201 Receives FDA Orphan-Drug Designation for the Treatment of Ascites
HSMN NewsFeed - 7 Sep 2016
FDA Grants Special Designation to TAXIS Pharmaceuticals Experimental Antibiotic
FDA Grants Special Designation to TAXIS Pharmaceuticals Experimental Antibiotic
HSMN NewsFeed - 18 Aug 2016
FDA Grants Soligenix Orphan Drug Designation for Dusquetide for Treatment of Macrophage Activation Syndrome
FDA Grants Soligenix Orphan Drug Designation for Dusquetide for Treatment of Macrophage Activation Syndrome
HSMN NewsFeed - 22 Jul 2016
ContraFect Corporation Names Steven C. Gilman, PhD Chief Executive Officer
ContraFect Corporation Names Steven C. Gilman, PhD Chief Executive Officer
HSMN NewsFeed - 18 Jul 2016
Citius Pharmaceuticals Completes Feasibility Study of Investigator Sites for Mino-Lok(TM) Phase 3 Trials
Citius Pharmaceuticals Completes Feasibility Study of Investigator Sites for Mino-Lok(TM) Phase 3 Trials
HSMN NewsFeed - 13 Jul 2016
SinuSys(TM) Corp. Receives FDA Clearance for the Vent-Os(R) Sinus Dilation Family of Devices
SinuSys(TM) Corp. Receives FDA Clearance for the Vent-Os(R) Sinus Dilation Family of Devices
HSMN NewsFeed - 31 May 2016
Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients
Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients
HSMN NewsFeed - 25 May 2016
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
HSMN NewsFeed - 11 May 2016
Isaac J. Bright, MD, Joins Synthetic Biologics as Vice President, Corporate Development
Isaac J. Bright, MD, Joins Synthetic Biologics as Vice President, Corporate Development
HSMN NewsFeed - 9 May 2016
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
HSMN NewsFeed - 9 May 2016
Synthetic Biologics Appoints Deb Mathews, PharmD, as Vice President, Medical Affairs
Synthetic Biologics Appoints Deb Mathews, PharmD, as Vice President, Medical Affairs
HSMN NewsFeed - 21 Mar 2016
FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis
FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis
HSMN NewsFeed - 17 Mar 2016
Biota Pharmaceuticals Announces Sale of Antibiotic Assets to Spero Therapeutics
Biota Pharmaceuticals Announces Sale of Antibiotic Assets to Spero Therapeutics
HSMN NewsFeed - 16 Feb 2016
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO(R) (ceftaroline fosamil)
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO(R) (ceftaroline fosamil)
HSMN NewsFeed - 9 Feb 2016
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
HSMN NewsFeed - 2 Feb 2016
BONESUPPORT(TM) Reports Expansion Of Company's CERAMENT(TM) Drug Eluting Procedure Registry
BONESUPPORT(TM) Reports Expansion Of Company's CERAMENT(TM) Drug Eluting Procedure Registry
HSMN NewsFeed - 23 Jan 2016
Cellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of Kevetrin for Pancreatic Cancer
Cellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of Kevetrin for Pancreatic Cancer
HSMN NewsFeed - 22 Jan 2016
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
HSMN NewsFeed - 21 Jan 2016
Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for DALVANCE(R) (dalbavancin)
Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for DALVANCE(R) (dalbavancin)
HSMN NewsFeed - 19 Jan 2016
Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection
Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection
HSMN NewsFeed - 21 Dec 2015
Roche receives FDA approval for HIV-1 viral load test on the cobas(R) 6800/8800 Systems
Roche receives FDA approval for HIV-1 viral load test on the cobas(R) 6800/8800 Systems
HSMN NewsFeed - 17 Dec 2015
Oculus Innovative Sciences Receives FDA Clearance for Microcyn(R)-Based SebDerm Gel
Oculus Innovative Sciences Receives FDA Clearance for Microcyn(R)-Based SebDerm Gel
HSMN NewsFeed - 1 Dec 2015
Roche And Upsher-Smith Announce License Agreement To Develop Novel VAP-1 Inhibitor
Roche And Upsher-Smith Announce License Agreement To Develop Novel VAP-1 Inhibitor
HSMN NewsFeed - 30 Nov 2015
OticPharma Appoints Keith A. Katkin as Chairman of the Board of Directors
OticPharma Appoints Keith A. Katkin as Chairman of the Board of Directors
HSMN NewsFeed - 18 Nov 2015
Otonomy Initiates Patient Enrollment in U.S. Phase 3 Clinical Trial of OTO-104 in Meniere's Disease
Otonomy Initiates Patient Enrollment in U.S. Phase 3 Clinical Trial of OTO-104 in Meniere's Disease
HSMN NewsFeed - 1 Oct 2015
Synthetic Biologics Appoints Raymond Stapleton, PhD, as Senior Vice President, Manufacturing
Synthetic Biologics Appoints Raymond Stapleton, PhD, as Senior Vice President, Manufacturing
HSMN NewsFeed - 26 May 2015
Roche receives FDA clearance for the cobas(R) Cdiff Test to detect Clostridium difficile
Roche receives FDA clearance for the cobas(R) Cdiff Test to detect Clostridium difficile
HSMN NewsFeed - 20 Apr 2015
Oasmia's Lead Cancer Product Paclical(R) Receives Market Approval in the Russian Federation
Oasmia's Lead Cancer Product Paclical(R) Receives Market Approval in the Russian Federation
HSMN NewsFeed - 5 Mar 2015
Tetraphase Pharmaceuticals Appoints Maria Stahl as Senior Vice President and General Counsel
Tetraphase Pharmaceuticals Appoints Maria Stahl as Senior Vice President and General Counsel
HSMN NewsFeed - 29 Dec 2014
Roche receives FDA Emergency Use Authorization for the LightMix(R) Ebola Zaire rRT-PCR Test
Roche receives FDA Emergency Use Authorization for the LightMix(R) Ebola Zaire rRT-PCR Test
HSMN NewsFeed - 5 Dec 2014
Basilea Announces Launch of Antibiotic Zevtera(R) (ceftobiprole medocaril) in Germany
Basilea Announces Launch of Antibiotic Zevtera(R) (ceftobiprole medocaril) in Germany
HSMN NewsFeed - 16 Sep 2014
Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners
Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners
HSMN NewsFeed - 25 Aug 2014
NovaBay Pharmaceuticals Deploys Direct Sales Force to Market i-Lid Cleanser Across the U.S.
NovaBay Pharmaceuticals Deploys Direct Sales Force to Market i-Lid Cleanser Across the U.S.
HSMN NewsFeed - 30 Jul 2014
invendo medical Appoints Nachum (Homi) Shamir to the Company's Board of Directors
invendo medical Appoints Nachum (Homi) Shamir to the Company's Board of Directors
HSMN NewsFeed - 21 Jul 2014
AngioDynamics Awarded Novation Innovative Technology Contract Covering BioFlo PICCs and BioFlo Ports
AngioDynamics Awarded Novation Innovative Technology Contract Covering BioFlo PICCs and BioFlo Ports
HSMN NewsFeed - 1 Jul 2014
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
HSMN NewsFeed - 18 Jun 2014
Lakewood-Amedex Raises $5.5 Million In Series C Preferred Stock Financing
Lakewood-Amedex Raises $5.5 Million In Series C Preferred Stock Financing
HSMN NewsFeed - 5 Jun 2014
ORBACTIV(TM) (Oritavancin) Phase 3 Trial Results Published in New England Journal of Medicine
ORBACTIV(TM) (Oritavancin) Phase 3 Trial Results Published in New England Journal of Medicine
HSMN NewsFeed - 20 May 2014
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 24 Apr 2014
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
HSMN NewsFeed - 5 Mar 2014
Independent Study Shows V.A.C. VeraFlo(TM) Therapy More Beneficial Than Traditional V.A.C.(R) Therapy
Independent Study Shows V.A.C. VeraFlo(TM) Therapy More Beneficial Than Traditional V.A.C.(R) Therapy
HSMN NewsFeed - 11 Feb 2014
Marvao Medical Receives second FDA Clearance for its NexSite(TM) HD Catheter product line
Marvao Medical Receives second FDA Clearance for its NexSite(TM) HD Catheter product line
HSMN NewsFeed - 7 Jan 2014
Gentle, Simple SinuSys(TM) Vent-Os(TM) Sinus Dilation System Obtains FDA Clearance
Gentle, Simple SinuSys(TM) Vent-Os(TM) Sinus Dilation System Obtains FDA Clearance
HSMN NewsFeed - 6 Jan 2014
Medtronic Announces Acquisition of TYRX, INC., Developer of Solutions for Surgical Site Infections
Medtronic Announces Acquisition of TYRX, INC., Developer of Solutions for Surgical Site Infections
HSMN NewsFeed - 30 Dec 2013
Electromed, Inc. Receives FDA Market Clearance for the SmartVest(R) SQL(TM)
Electromed, Inc. Receives FDA Market Clearance for the SmartVest(R) SQL(TM)
HSMN NewsFeed - 30 Dec 2013
Cubist Announces FDA Acceptance of Tedizolid New Drug Application with Priority Review
Cubist Announces FDA Acceptance of Tedizolid New Drug Application with Priority Review
HSMN NewsFeed - 30 Dec 2013
FDA Approves SALMONELEX(TM) Against Salmonella as New Food Processing Aid
FDA Approves SALMONELEX(TM) Against Salmonella as New Food Processing Aid
HSMN NewsFeed - 20 Dec 2013
Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis with US FDA
Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis with US FDA
HSMN NewsFeed - 15 Nov 2013
Germ-Zapping Robots Use Xenex’s Powerful, Pulsed UV Light to Improve Patient Safety at University Hospital
Germ-Zapping Robots Use Xenex’s Powerful, Pulsed UV Light to Improve Patient Safety at University Hospital
HSMN NewsFeed - 13 Nov 2013
Jade Therapeutics Elects Veteran Life Science Entrepreneur Dinesh Patel, Ph.D., to its Board of Directors
Jade Therapeutics Elects Veteran Life Science Entrepreneur Dinesh Patel, Ph.D., to its Board of Directors
HSMN NewsFeed - 3 Oct 2013
AngioDynamics Announces First Patient Enrolled in PICC Related Obstruction of Flow (PROOF) Study
AngioDynamics Announces First Patient Enrolled in PICC Related Obstruction of Flow (PROOF) Study
HSMN NewsFeed - 16 Sep 2013
FDA Grants Soligenix Orphan Drug Designation for SGX94 for Treatment of Acute Radiation Syndrome
FDA Grants Soligenix Orphan Drug Designation for SGX94 for Treatment of Acute Radiation Syndrome
HSMN NewsFeed - 3 Sep 2013
Aptalis Pharma(TM) Launches PYLERA(R) 10 Day Therapy PAK in the United States
Aptalis Pharma(TM) Launches PYLERA(R) 10 Day Therapy PAK in the United States
HSMN NewsFeed - 20 Aug 2013
AngioDynamics Earns FDA Clearance for Ports With BioFlo Technology to Reduce Catheter-Related Thrombus
AngioDynamics Earns FDA Clearance for Ports With BioFlo Technology to Reduce Catheter-Related Thrombus
HSMN NewsFeed - 25 Jun 2013
BioFire Receives FDA Clearance for the FilmArray(R) Blood Culture Identification Panel
BioFire Receives FDA Clearance for the FilmArray(R) Blood Culture Identification Panel
HSMN NewsFeed - 28 May 2013
ULURU Inc. Announces Publication On Altrazeal(R) In The International Journal Of Molecular Sciences
ULURU Inc. Announces Publication On Altrazeal(R) In The International Journal Of Molecular Sciences
HSMN NewsFeed - 24 May 2013
PBAC Approves XIFAXAN(R) (Rifaxamin α) 550 mg Cost Effectiveness in Australia
PBAC Approves XIFAXAN(R) (Rifaxamin α) 550 mg Cost Effectiveness in Australia
HSMN NewsFeed - 15 May 2013
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Advanced Liver Cancer
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Advanced Liver Cancer
HSMN NewsFeed - 1 May 2013
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
HSMN NewsFeed - 19 Apr 2013
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
HSMN NewsFeed - 18 Apr 2013
New Anti-Infectives Company, Allecra Therapeutics, Created With €15 Million Series A Financing
New Anti-Infectives Company, Allecra Therapeutics, Created With €15 Million Series A Financing
HSMN NewsFeed - 27 Mar 2013
AdvanDx, Inc. Elects Former Roche Molecular Systems CEO, Heiner Dreismann, Ph.D., to its Board of Directors
AdvanDx, Inc. Elects Former Roche Molecular Systems CEO, Heiner Dreismann, Ph.D., to its Board of Directors
HSMN NewsFeed - 28 Feb 2013
FDA Grants QIDP and Fast Track Designations for Cubist’s Late-Stage Antibiotic Candidates
FDA Grants QIDP and Fast Track Designations for Cubist’s Late-Stage Antibiotic Candidates
HSMN NewsFeed - 25 Feb 2013
First U.S. Patients Treated in PneumRx RENEW Pivotal Study for Treatment of Severe Emphysema
First U.S. Patients Treated in PneumRx RENEW Pivotal Study for Treatment of Severe Emphysema
HSMN NewsFeed - 13 Feb 2013
Sobi gains distribution rights for Megace(R), Monopril(R), Cefzil(R); and Duricef(R); from PharmaSwiss
Sobi gains distribution rights for Megace(R), Monopril(R), Cefzil(R); and Duricef(R); from PharmaSwiss
HSMN NewsFeed - 6 Feb 2013
Smiths Medical Receives FDA Clearance for CADD-Solis VIP Ambulatory Infusion System
Smiths Medical Receives FDA Clearance for CADD-Solis VIP Ambulatory Infusion System
HSMN NewsFeed - 11 Dec 2012
Pernix Therapeutics Announces Agreement to Acquire Somaxon Pharmaceuticals, Inc.
Pernix Therapeutics Announces Agreement to Acquire Somaxon Pharmaceuticals, Inc.
HSMN NewsFeed - 26 Oct 2012
NICE Approves Pharmaxis' Bronchitol(R) As An Important New Treatment Option For Cystic Fibrosis Patients
NICE Approves Pharmaxis' Bronchitol(R) As An Important New Treatment Option For Cystic Fibrosis Patients
HSMN NewsFeed - 16 Oct 2012
BioAdvance Expands Team to Support Portfolio Companies and New Investments
BioAdvance Expands Team to Support Portfolio Companies and New Investments
HSMN NewsFeed - 13 Sep 2012
NovaBay's NeutroPhase(R) Used in New Therapeutic Technique for Management of Necrotizing Fasciitis
NovaBay's NeutroPhase(R) Used in New Therapeutic Technique for Management of Necrotizing Fasciitis
HSMN NewsFeed - 4 Sep 2012
Vertex Announces Appointment of Stuart A. Arbuckle as Chief Commercial Officer
Vertex Announces Appointment of Stuart A. Arbuckle as Chief Commercial Officer
HSMN NewsFeed - 17 Apr 2012
QIAGEN Receives FDA Clearances for Rotor-Gene Q MDx Instrument and Compatible Influenza A/B Assay
QIAGEN Receives FDA Clearances for Rotor-Gene Q MDx Instrument and Compatible Influenza A/B Assay
HSMN NewsFeed - 7 Mar 2012
Pernix Therapeutics Provides Business Update and Announces New Product Development Agreement
Pernix Therapeutics Provides Business Update and Announces New Product Development Agreement
HSMN NewsFeed - 24 Feb 2012
Forest Laboratories Receives European Marketing Approval for Colobreathe(R) Dry Powder Inhaler
Forest Laboratories Receives European Marketing Approval for Colobreathe(R) Dry Powder Inhaler
HSMN NewsFeed - 18 Nov 2011
EUSA Pharma Announces FDA Approval of Orphan Drug ERWINAZE(TM) for Treatment of Acute Lymphoblastic Leukemia
EUSA Pharma Announces FDA Approval of Orphan Drug ERWINAZE(TM) for Treatment of Acute Lymphoblastic Leukemia
HSMN NewsFeed - 14 Oct 2011
NovaBay Pharmaceuticals Spotlights NeutroPhase(R) at the Symposium on Advanced Wound Care (SAWC)
NovaBay Pharmaceuticals Spotlights NeutroPhase(R) at the Symposium on Advanced Wound Care (SAWC)
HSMN NewsFeed - 12 Oct 2011
Onyx Pharmaceuticals and Bayer Healthcare Restructure Global Oncology Partnership
Onyx Pharmaceuticals and Bayer Healthcare Restructure Global Oncology Partnership
HSMN NewsFeed - 4 Oct 2011
NovaBay Pharmaceuticals Names David W. Stroman, Ph.D. as Head of Ophthalmic Drug Development
NovaBay Pharmaceuticals Names David W. Stroman, Ph.D. as Head of Ophthalmic Drug Development
HSMN NewsFeed - 28 Sep 2011
NovaBay Pharmaceuticals Names Russell A. Hoon as Vice President of Its Advanced Wound Care Business Unit
NovaBay Pharmaceuticals Names Russell A. Hoon as Vice President of Its Advanced Wound Care Business Unit
HSMN NewsFeed - 4 Apr 2011
Anacor Pharmaceuticals Appoints William J. Rieflin to Its Board of Directors
Anacor Pharmaceuticals Appoints William J. Rieflin to Its Board of Directors
HSMN NewsFeed - 18 Feb 2011
Impax Laboratories Receives Final FDA Approval for Generic Adoxa(R) 150 mg Capsules
Impax Laboratories Receives Final FDA Approval for Generic Adoxa(R) 150 mg Capsules
HSMN NewsFeed - 3 Feb 2011
Otonomy Adds Key Product and Industry Experience with Appointment of New Vice Presidents
Otonomy Adds Key Product and Industry Experience with Appointment of New Vice Presidents
HSMN NewsFeed - 17 Jan 2011
AdvanDx Receives FDA 510(k) Clearance for GNR Traffic Light(TM) PNA FISH(R)
AdvanDx Receives FDA 510(k) Clearance for GNR Traffic Light(TM) PNA FISH(R)
HSMN NewsFeed - 5 Jan 2011
Cempra Pharmaceuticals Names Carl Foster Executive Vice President of Business Development
Cempra Pharmaceuticals Names Carl Foster Executive Vice President of Business Development
HSMN NewsFeed - 3 Jan 2011
Inspire Announces Results of Second Phase 3 Trial with Denufosol for Cystic Fibrosis
Inspire Announces Results of Second Phase 3 Trial with Denufosol for Cystic Fibrosis
HSMN NewsFeed - 1 Dec 2010
Cubist Pharmaceuticals Receives FDA Approval for 2-Minute IV Injection of CUBICIN
Cubist Pharmaceuticals Receives FDA Approval for 2-Minute IV Injection of CUBICIN
HSMN NewsFeed - 17 Nov 2010
PolyMedix Appoints Steffen Helmling, Ph.D. as Vice President of Business Development
PolyMedix Appoints Steffen Helmling, Ph.D. as Vice President of Business Development
HSMN NewsFeed - 27 Oct 2010
Laurence J. Downey, MD Joins Arbor Pharmaceuticals as Vice President of Medical Affairs
Laurence J. Downey, MD Joins Arbor Pharmaceuticals as Vice President of Medical Affairs
HSMN NewsFeed - 12 Oct 2010
Cempra Pharmaceuticals Names Richard Kent, M.D., to Its Board of Directors
Cempra Pharmaceuticals Names Richard Kent, M.D., to Its Board of Directors
HSMN NewsFeed - 5 Oct 2010
Anacor Pharmaceuticals Appoints Geoffrey M. Parker as Chief Financial Officer
Anacor Pharmaceuticals Appoints Geoffrey M. Parker as Chief Financial Officer
HSMN NewsFeed - 7 Sep 2010
NeoStem Appoints Distinguished Businessman as New President and Managing Director NeoStem China
NeoStem Appoints Distinguished Businessman as New President and Managing Director NeoStem China
HSMN NewsFeed - 24 Aug 2010
Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors
Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors
HSMN NewsFeed - 10 Aug 2010
Advanced Life Sciences Achieves Special Protocol Assessment Agreement With FDA for Restanza in Pneumonia
Advanced Life Sciences Achieves Special Protocol Assessment Agreement With FDA for Restanza in Pneumonia
HSMN NewsFeed - 2 Jun 2010
Oculus Innovative Sciences Launches Microcyn(R) Negative-Pressure Wound Therapy Solution for U.S. Market
Oculus Innovative Sciences Launches Microcyn(R) Negative-Pressure Wound Therapy Solution for U.S. Market
HSMN NewsFeed - 12 May 2010
Sagent Pharmaceuticals Announces FDA Approval of Bacitracin for Injection, USP
Sagent Pharmaceuticals Announces FDA Approval of Bacitracin for Injection, USP
HSMN NewsFeed - 7 May 2010
Recordati Signs an Agreement With Zambon for the Co-Marketing of Silodosin in France
Recordati Signs an Agreement With Zambon for the Co-Marketing of Silodosin in France
HSMN NewsFeed - 6 May 2010
Cempra Pharmaceuticals Names Mark W. Hahn as Executive Vice President and Chief Financial Officer
Cempra Pharmaceuticals Names Mark W. Hahn as Executive Vice President and Chief Financial Officer
HSMN NewsFeed - 13 Apr 2010
New Anti-Bacterial Device Helps Reduce Infections Associated with Pacemaker and Defibrillator Implantation*
New Anti-Bacterial Device Helps Reduce Infections Associated with Pacemaker and Defibrillator Implantation*
HSMN NewsFeed - 24 Mar 2010
FDA Approves XIFAXAN(R) 550 MG Tablets for Reduction in Risk of Overt Hepatic Encephalopathy (HE) Recurrence
FDA Approves XIFAXAN(R) 550 MG Tablets for Reduction in Risk of Overt Hepatic Encephalopathy (HE) Recurrence
HSMN NewsFeed - 24 Mar 2010
TYRX Enrolls First Patient in CITADEL Study for AIGISRx Anti-Bacterial Envelope with ICD Replacements
TYRX Enrolls First Patient in CITADEL Study for AIGISRx Anti-Bacterial Envelope with ICD Replacements
HSMN NewsFeed - 23 Mar 2010
New Device Advances the Treatment of Pediatric Vesicoureteral Reflux (VUR)
New Device Advances the Treatment of Pediatric Vesicoureteral Reflux (VUR)
HSMN NewsFeed - 26 Jan 2010
Prometheus Acquires Exclusive Rights to PROLEUKIN(R) (aldesleukin) in the U.S.
Prometheus Acquires Exclusive Rights to PROLEUKIN(R) (aldesleukin) in the U.S.
Additional items found! 500

Members Archive contains
500 additional stories matching:
antibiotic
(Password required)
antibiotic
(Password required)